149 related articles for article (PubMed ID: 24347984)
21. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.
Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B
Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590
[TBL] [Abstract][Full Text] [Related]
22. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
[TBL] [Abstract][Full Text] [Related]
23. [Safety and tolerability of psychotropic medications in childhood: preliminary data of a pharmacovigilance study].
Magazù A; Masi G; Germanò E; Gagliostro MS; Siracusano R; Arcoraci V; Spina E; Gagliano A
Minerva Pediatr; 2014 Jun; 66(3):187-99. PubMed ID: 24826975
[TBL] [Abstract][Full Text] [Related]
24. Time series analysis of using the PDCA method combined with the Teach-back method to improve spontaneous reports of adverse drug reactions in a grade IIIA hospital in China.
Li B; Jiang L; Liao L; Chen Y; Xu Z; Wu N; Chen H; Wu P; Liu T
Eur J Clin Pharmacol; 2024 Mar; 80(3):383-393. PubMed ID: 38151504
[TBL] [Abstract][Full Text] [Related]
25. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.
Lapi F; Tuccori M; Motola D; Pugi A; Vietri M; Montanaro N; Vaccheri A; Leoni O; Cocci A; Leone R; Conforti A; Moretti U; Sessa E; Mazzaglia G; Mugelli A; Mazzei T; Vannacci A
Drug Saf; 2010 Sep; 33(9):789-99. PubMed ID: 20701411
[TBL] [Abstract][Full Text] [Related]
26. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
27. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
28. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
[TBL] [Abstract][Full Text] [Related]
29. Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.
Prakash J; Sachdeva R; Shrivastava TP; Jayachandran CV; Sahu A
Indian J Pharmacol; 2021; 53(2):143-152. PubMed ID: 34100398
[TBL] [Abstract][Full Text] [Related]
30. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
[TBL] [Abstract][Full Text] [Related]
31. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
32. Perceptions, practices and barriers to reporting of adverse drug reactions among HIV infected patients and their doctors in 3 public sector hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a cross sectional and retrospective analysis.
Zondi S; Naidoo P
BMC Health Serv Res; 2022 Aug; 22(1):1054. PubMed ID: 35982442
[TBL] [Abstract][Full Text] [Related]
33. Adverse Drug Reactions of Acetaminophen and Ibuprofen in the Paediatric Population: Analysis of the Italian Spontaneous Reporting Database.
Pelliccia V; Rossi S; Zollino I; Quagliarella F; Buonocore G
Curr Pediatr Rev; 2022; 18(1):64-71. PubMed ID: 34503427
[TBL] [Abstract][Full Text] [Related]
34. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
[TBL] [Abstract][Full Text] [Related]
35. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
36. [A retrospective pharmacovigilance analysis: could decreased reporting of suspected adverse reactions generate future safety concerns?].
Ferrara F; Mancaniello C; Nava L; Salierno A; Casillo R; Trama U; Nava E; Vitiello A
Recenti Prog Med; 2022 Mar; 113(3):198-201. PubMed ID: 35315450
[TBL] [Abstract][Full Text] [Related]
37. FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.
Fracchiolla NS; Artuso S; Cortelezzi A; Pelizzari AM; Tozzi P; Bonfichi M; Bocchio F; Gargantini L; De Rosa E; Vighi GD; Prestini L; Sammassimo S; Frungillo N; Pasquini MC; Ragazzi A; Boghi D; Pastore A; Lanzi E; Gritti G; Quaresmini G; Voltolini S; Gaiardoni R; Corti C; Vilardo MC; La Targia ML; Berini G; Magagnoli M; Bacci C; Consonni D; Rivolta AL; Muti G
Hematol Oncol; 2018 Feb; 36(1):299-306. PubMed ID: 28771763
[TBL] [Abstract][Full Text] [Related]
38. Use and safety profile of antiepileptic drugs in Italy.
Iorio ML; Moretti U; Colcera S; Magro L; Meneghelli I; Motola D; Rivolta AL; Salvo F; Velo GP
Eur J Clin Pharmacol; 2007 Apr; 63(4):409-15. PubMed ID: 17347806
[TBL] [Abstract][Full Text] [Related]
39. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
40. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.
Gustafsson M; Matos C; Joaquim J; Scholl J; van Hunsel F
Drug Saf; 2023 Nov; 46(11):1133-1148. PubMed ID: 37824028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
